DRUG · Unmapped registry intervention
SM-13496
Find medicine records ·
Find other trials using this name
Clinical trial
Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
NCT01614912
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedLong-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
SM-13496DRUG
Sponsors & collaborators
Sumitomo Pharma Co., Ltd.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01614912 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.